SXI Life Sciences
6 673,38
|
-194,45
|
-2,83%
|
Analysen zu SXI Life Sciences-Werten
04.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
04.07.24 | Roche Neutral | UBS AG | |
04.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
03.07.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
02.07.24 | Roche Hold | Jefferies & Company Inc. | |
02.07.24 | Novartis Buy | Jefferies & Company Inc. | |
02.07.24 | Novartis Buy | Deutsche Bank AG | |
02.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
01.07.24 | Roche Hold | Deutsche Bank AG | |
01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
24.06.24 | Roche Equal Weight | Barclays Capital | |
24.06.24 | Novartis Underweight | Barclays Capital | |
20.06.24 | Roche Neutral | UBS AG | |
17.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
17.06.24 | Roche Hold | Deutsche Bank AG | |
17.06.24 | Roche Equal Weight | Barclays Capital | |
17.06.24 | Roche Underweight | JP Morgan Chase & Co. | |
11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
05.06.24 | Novartis Buy | Deutsche Bank AG | |
03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
03.06.24 | Roche Hold | Deutsche Bank AG | |
03.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
03.06.24 | Novartis Buy | UBS AG | |
31.05.24 | Roche Neutral | UBS AG | |
31.05.24 | Novartis Buy | UBS AG | |
31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
30.05.24 | Roche Sell | Goldman Sachs Group Inc. | |
30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
24.05.24 | Roche Hold | Deutsche Bank AG | |
24.05.24 | Novartis Buy | Deutsche Bank AG | |
23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
17.05.24 | Roche Neutral | UBS AG | |
17.05.24 | Roche Hold | Deutsche Bank AG | |
16.05.24 | Roche Underweight | JP Morgan Chase & Co. | |
16.05.24 | Roche Hold | Jefferies & Company Inc. | |
14.05.24 | Roche Neutral | UBS AG | |
06.05.24 | Roche Neutral | UBS AG | |
06.05.24 | Novartis Buy | UBS AG |